Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib (Q46105334)
Jump to navigation
Jump to search
scientific article published on 10 July 2013
Language | Label | Description | Also known as |
---|---|---|---|
English | Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib |
scientific article published on 10 July 2013 |
Statements
1 reference
Impact of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) gene dosage on plasma pharmacokinetics and brain accumulation of dasatinib, sorafenib, and sunitinib (English)
1 reference
Jos H Beijnen
1 reference
Seng Chuan Tang
1 reference
Niels de Vries
1 reference
Rolf W Sparidans
1 reference
Els Wagenaar
1 reference
Alfred H Schinkel
1 reference
10 July 2013
1 reference
346
1 reference
486-494
1 reference
3
1 reference
Identifiers
1 reference
1 reference